Drug Type Small molecule drug |
Synonyms BS-5930, Disipal |
Target |
Action antagonists |
Mechanism mAChRs antagonists(Muscarinic acetylcholine receptor antagonists) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseWithdrawn |
First Approval Date United States (10 May 1957), |
Regulation- |
Molecular FormulaC18H24ClNO |
InChIKeyUQZKYYIKWZOKKD-UHFFFAOYSA-N |
CAS Registry341-69-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D02599 | Orphenadrine Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Musculoskeletal Pain | United States | 10 May 1957 | |
Parkinson Disease | United States | 10 May 1957 |
Phase 4 | 240 | Placebo+Naproxen (Placebo) | quiaefmewr(azqroylzzt) = tmfuzeqzfk biormpxkoa (vyujayzdgs, tuvwtuguyl - dshhxslrhj) View more | - | 26 Jun 2018 | ||
(Orphenadrine) | quiaefmewr(azqroylzzt) = xipfaadtop biormpxkoa (vyujayzdgs, lkrincegga - mfqnaagzhs) View more |